Ingredient Safety

Browse Ingredient Safety Content

Today, the Consumer Healthcare Products Association (CHPA) submitted comments to the U.S. Food and Drug Administration (FDA) in response to a Citizen Petition from the Environmental Defense Fund (EDF) asking FDA to revoke the use of the colorant titanium dioxide (TiO2) in foods, including dietary supplements.

Aug 31, 2023

CHPA strongly urges the Food and Drug Administration to deny the petition to repeal 21 CFR 73.575, which permits the use of TiO2 in food and dietary supplements. Based on extensive scientific research and regulatory evaluations, TiO2 is deemed safe for use as a food additive when consumed within established regulatory limits.

Aug 29, 2023

CHPA appreciates this opportunity to comment on the Synthetic Dye Petition submitted to the California Department of Public Health requesting that a warning be placed on food and dietary supplement products related to adverse neurobehavioral effects purportedly associated with ingestion of synthetic food dyes.

May 12, 2023

CHPA’s SVP of Dietary Supplements, Duffy MacKay, responds to reporting on a recent research letter published in JAMA finding that 22 out of 25 melatonin products analyzed were mislabeled, containing variable amounts of the ingredient:

Apr 25, 2023

CHPA appreciates the opportunity to provide comments on NIH ODS strategic plan 2022-2026.

Sep 1, 2022

New online resource aims to help consumers better understand what information to look for on the Supplement Facts label when shopping for dietary supplements.

Jan 19, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Oct 13, 2021

ACI and CHPA praise FDA for announcing the withdrawal of its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

Oct 12, 2021

Filter Results